Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals

SIMPLE SUMMARY: Proton pump inhibitors are commonly prescribed medications for gastrointestinal disorders, which bring gastric acid down to normal levels. However, the effects of PPI on pancreatic risk remain unclear. Therefore, we conducted a systematic review and meta-analysis to investigate the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Poly, Tahmina Nasrin, Islam, Md. Mohaimenul, Walther, Bruno Andreas, Lin, Ming-Chin, Li, Yu-Chuan (Jack)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658965/
https://www.ncbi.nlm.nih.gov/pubmed/36358776
http://dx.doi.org/10.3390/cancers14215357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658965/
https://www.ncbi.nlm.nih.gov/pubmed/36358776
http://dx.doi.org/10.3390/cancers14215357

Ejemplares similares